Search Results
Search for other papers by Annamaria Erdei in
Google Scholar
PubMed
Search for other papers by Annamaria Gazdag in
Google Scholar
PubMed
Search for other papers by Bernadett Ujhelyi in
Google Scholar
PubMed
Search for other papers by Edit B Nagy in
Google Scholar
PubMed
Search for other papers by Ervin Berenyi in
Google Scholar
PubMed
Search for other papers by Eszter Berta in
Google Scholar
PubMed
Search for other papers by Zita Steiber in
Google Scholar
PubMed
Search for other papers by Sandor Barna in
Google Scholar
PubMed
Search for other papers by Emese Mezosi in
Google Scholar
PubMed
Search for other papers by Miklos Bodor in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
Introduction
Dysthyroid optic neuropathy (DON) is a rare, severe form of thyroid eye disease, in which decreased visual acuity is accompanied by characteristic MRI findings. The treatment of DON has always been a challenge.
Case presentation
In a patient in whom visual acuity deteriorated on the left eye, mannitol 20% 200 mL followed by furosemide 40 mg 6 h later, administered daily, were initiated on the day of admission. Visual function by ophthalmology methods, and orbital compartment volumes and water content by MRI were followed. Intravenous diuretics resulted in an immediate therapeutic response. Visual acuity improved from 20/50 to 20/25 after 2 days of treatment. MRI revealed decreasing water content of both the muscle and connective tissue compartments without any volume changes. Subsequently, corticosteroids and orbital irradiation were started. Orbital decompression surgery was not required.
Discussion/conclusion
Edematous swelling of orbital tissues is an established contributor of local pressure increase in thyroid eye disease. Diuretics reduce orbital pressure and, if confirmed by others, may be useful additions to the standard of care in sight-threatening DON.